Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -14.26%309.05M | ---- | -30.13%360.47M | ---- | 12.15%515.9M | ---- | 124.50%460M | ---- | 25.87%204.9M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 10.57%-13.41M | ---- | -174.51%-14.99M | ---- | -82.15%-5.46M | ---- | -2.71%-3M | ---- | 21.87%-2.92M |
| Attributable subsidiary (profit) loss | ---- | -44.31%-6.4M | ---- | -1,083.37%-4.44M | ---- | -56.09%451K | ---- | -86.82%1.03M | ---- | 125.01%7.79M |
| Impairment and provisions: | ---- | -182.37%-22.02M | ---- | 678.97%26.74M | ---- | -148.66%-4.62M | ---- | 181.56%9.49M | ---- | -132.30%-11.64M |
| -Impairmen of inventory (reversal) | ---- | 68.42%4.42M | ---- | 634.01%2.62M | ---- | -105.45%-491K | ---- | 131.08%9.02M | ---- | -256.80%-29.01M |
| -Impairment of trade receivables (reversal) | ---- | -209.64%-26.44M | ---- | 684.32%24.12M | ---- | -970.68%-4.13M | ---- | -97.27%474K | ---- | -0.86%17.37M |
| Asset sale loss (gain): | ---- | --774K | ---- | ---- | ---- | -235.94%-48.91M | ---- | -132,263.64%-14.56M | ---- | 99.84%-11K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | -235.94%-48.91M | ---- | ---14.56M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | --774K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.85%-11K |
| Depreciation and amortization: | ---- | -32.55%28.42M | ---- | 112.35%42.14M | ---- | -8.58%19.84M | ---- | -91.24%21.71M | ---- | 143.41%247.85M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 155.80%226.42M |
| Financial expense | ---- | 14.61%125.26M | ---- | 61.33%109.3M | ---- | 43.22%67.75M | ---- | 427.64%47.3M | ---- | -83.96%8.97M |
| Special items | ---- | -34.46%177.62M | ---- | -1.59%271M | ---- | -10.89%275.38M | ---- | 8,286.49%309.04M | ---- | -78.18%3.69M |
| Operating profit before the change of operating capital | ---- | -24.16%599.3M | ---- | -3.67%790.21M | ---- | -1.29%820.33M | ---- | 81.20%831.01M | ---- | 38.24%458.62M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 289.76%874.33M | ---- | 78.83%-460.75M | ---- | -26.01%-2.18B | ---- | -426.44%-1.73B | ---- | -158.89%-328.12M |
| Accounts receivable (increase)decrease | ---- | 26.23%-360.18M | ---- | -183.83%-488.25M | ---- | 179.98%582.45M | ---- | -710.85%-728.21M | ---- | -13.92%-89.81M |
| Accounts payable increase (decrease) | ---- | -443.73%-900.65M | ---- | -109.94%-165.64M | ---- | 30.62%1.67B | ---- | 781.08%1.28B | ---- | -191.80%-187.39M |
| Special items for working capital changes | ---- | 69.04%-52.02M | ---- | -10.93%-168.04M | ---- | -93.55%-151.48M | ---- | -518.27%-78.26M | ---- | 106.36%18.71M |
| Cash from business operations | 98.08%105.69M | 132.65%160.77M | 111.01%53.36M | -166.40%-492.48M | -372.67%-484.61M | 273.88%741.66M | 4,093.87%177.73M | -229.60%-426.54M | -101.66%-4.45M | -54.30%329.12M |
| Other taxs | -19.60%-22.95M | 64.43%-28.76M | 66.24%-19.19M | 2.80%-80.86M | -26.65%-56.85M | -351.36%-83.19M | -390.08%-44.89M | 22.54%-18.43M | 29.27%-9.16M | -201.42%-23.79M |
| Interest received - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --457.11M |
| Special items of business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---457.11M |
| Net cash from operations | 142.15%82.74M | 123.03%132.01M | 106.31%34.17M | -187.07%-573.34M | -507.60%-541.46M | 247.98%658.47M | 1,076.13%132.84M | -245.74%-444.97M | -105.34%-13.61M | -57.13%305.33M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -7.47%6.72M | -10.57%13.41M | 14.16%7.27M | 174.51%14.99M | 924.96%6.37M | 82.15%5.46M | -5.77%621K | 2.71%3M | 12.46%659K | -21.87%2.92M |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -63.39%320K | -41.01%525K | -91.78%874K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | --18.06M | ---- | ---- | 183.94%79.04M | ---- | -88.84%27.84M |
| Decrease in deposits (increase) | -1,522.07%-491.41M | 157.89%56.25M | 90.05%-30.3M | -150.75%-97.17M | -715.09%-304.55M | 182.78%191.47M | 845.63%49.51M | -9,267.86%-231.31M | -84.98%5.24M | -98.92%2.52M |
| Purchase of fixed assets | -2,303.64%-8.58M | 62.27%-3.33M | 39.39%-357K | -529.58%-8.83M | 63.10%-589K | 12.09%-1.4M | 6.28%-1.6M | 41.67%-1.6M | -24.31%-1.7M | -40.16%-2.74M |
| Purchase of intangible assets | -3,554.73%-7.35M | 82.63%-27.66M | 99.79%-201K | 40.84%-159.2M | ---94.79M | -102.18%-269.09M | ---- | 54.10%-133.1M | 13.68%-135.98M | 60.18%-289.97M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | -87.67%17.18M | 89,527.59%25.93M | 51,703.35%139.35M | ---29K | --269K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | -411.84%-134.79M | --42.73M | --43.22M | ---- |
| Recovery of cash from investments | --20.78M | 80.00%10.8M | ---- | --6M | ---1.45M | ---- | ---- | 66.54%25M | --25.21M | -92.46%15.01M |
| Cash on investment | ---- | ---110M | ---- | ---- | ---98.82M | -205.38%-366.24M | ---- | -199.83%-119.93M | ---- | 88.40%-40M |
| Net cash from investment operations | -1,934.29%-479.83M | 75.21%-60.54M | 95.04%-23.59M | 42.22%-244.21M | -688.83%-475.77M | -115.08%-422.62M | 4.05%-60.31M | 30.63%-196.49M | 48.72%-62.86M | 24.35%-283.27M |
| Net cash before financing | -3,852.85%-397.09M | 108.74%71.47M | 101.04%10.58M | -446.64%-817.55M | -1,502.52%-1.02B | 136.77%235.85M | 194.85%72.53M | -3,008.61%-641.46M | -157.83%-76.47M | -93.47%22.05M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 202.74%2.76B | -32.31%1.88B | -49.45%912.75M | 105.83%2.78B | 69.20%1.81B | 34.87%1.35B | 171.96%1.07B | 581.84%1B | 16.56%392.42M | -67.75%146.8M |
| Refund | -173.16%-2.17B | 22.64%-1.61B | 10.46%-795.18M | -142.02%-2.08B | -37.74%-888.12M | -18.16%-860.82M | -88.33%-644.78M | -298.11%-728.53M | 8.54%-342.37M | 87.05%-183M |
| Issuing shares | --298.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | -112.44%-79.66M | -50.62%-99.09M | -16.77%-37.5M | -156.54%-65.79M | -299.04%-32.12M | -447.01%-25.64M | -181.60%-8.05M | 47.71%-4.69M | 46.36%-2.86M | 83.96%-8.97M |
| Dividends paid - financing | ---- | 5.06%-47.85M | ---- | ---50.4M | ---- | ---- | ---- | -331.25%-13.04M | -344.84%-13.45M | ---3.02M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -56.77%162.92M | --162.92M | --376.9M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---41.65M | ---- | ---- | ---- | 93.06%-9.14M |
| Other items of the financing business | -407.19%-93.6M | -174.17%-14.67M | -423.58%-18.45M | 115.29%19.78M | 219.67%5.7M | ---129.35M | -18.58%1.78M | ---- | -37.13%2.19M | -404.56%-26.06M |
| Net cash from financing operations | 1,314.05%708.21M | -84.94%86.55M | -94.31%50.08M | 111.40%574.82M | 118.11%880.55M | -31.34%271.91M | 111.81%403.72M | 43.35%395.99M | 414.99%190.6M | 124.09%276.25M |
| Effect of rate | -409.50%-15.44M | 204.16%12.43M | -64.09%4.99M | -86.97%4.09M | -67.40%13.89M | 249.83%31.37M | 1,210.42%42.61M | -44.71%-20.93M | -115.35%-3.84M | -962.61%-14.47M |
| Net Cash | 412.86%311.12M | 165.10%158.02M | 144.39%60.67M | -147.80%-242.73M | -128.70%-136.68M | 306.85%507.76M | 317.28%476.25M | -182.29%-245.47M | 59.14%114.13M | 136.88%298.3M |
| Begining period cash | 38.94%608.23M | -35.28%437.78M | -35.28%437.78M | 392.68%676.42M | 392.68%676.42M | -65.99%137.3M | -65.99%137.3M | 236.80%403.7M | 236.80%403.7M | -87.07%119.87M |
| Cash at the end | 79.55%903.92M | 38.94%608.23M | -9.07%503.43M | -35.28%437.78M | -15.62%553.63M | 392.68%676.42M | 27.66%656.15M | -65.99%137.3M | 137.32%514M | 236.80%403.7M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Shin Yong Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin Yong Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.